Published in PLoS One on May 05, 2015
Be rich or don't be sick: estimating Vietnamese patients' risk of falling into destitution. Springerplus (2015) 3.62
Global Economic Burden of Norovirus Gastroenteritis. PLoS One (2016) 0.94
Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? Appl Health Econ Health Policy (2016) 0.78
On the measurement of inequalities in health. Soc Sci Med (1991) 14.79
Catastrophic payments for health care in Asia. Health Econ (2007) 5.16
Global mortality associated with rotavirus disease among children in 2004. J Infect Dis (2009) 3.63
Understanding the impact of eliminating user fees: utilization and catastrophic health expenditures in Uganda. Soc Sci Med (2005) 3.03
Rotavirus vaccines. WHO position paper – January 2013. Wkly Epidemiol Rec (2013) 2.15
Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine (2009) 1.39
Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health (2012) 1.23
Public finance of rotavirus vaccination in India and Ethiopia: an extended cost-effectiveness analysis. Vaccine (2013) 1.14
Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine (2012) 1.11
Out-of-pocket costs associated with rotavirus gastroenteritis requiring hospitalization in Malaysia. Vaccine (2009) 0.92
Estimates of the burden of rotavirus disease in Malaysia. J Infect Dis (2005) 0.92
Healthcare financing in Malaysia. Asia Pac J Public Health (2002) 0.85
Estimates of economic burden of providing inpatient care in childhood rotavirus gastroenteritis from Malaysia. J Paediatr Child Health (2007) 0.84
Evaluation of rotavirus vaccines in Asia--are there lessons to be learnt? Vaccine (2009) 0.81
Rotavirus genotypes in Malaysia and universal rotavirus vaccination. Hum Vaccin Immunother (2012) 0.78